Firebrick Pharma Ltd: Appendix 4D & Half-Year Financial Report to 31 December 2024

ASXFeb 19 23:20 ET · Announcements

Firebrick Pharma Signs License, Distribution Agreement to Sell Nasal Spray in Fiji, South Pacific, Shares Down 4%

MT NewswiresFeb 11 22:23 ET

Firebrick Pharma Removes Nasal Spray Competitor in Singapore for Patent Violation

MT NewswiresJan 13 20:22 ET

Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico

MT NewswiresOct 31, 2024 22:46 ET

Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results

MT NewswiresSep 25, 2024 03:00 ET

Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%

MT NewswiresSep 17, 2024 01:45 ET